Coya Therapeutics Inc (NASDAQ:COYA) has a beta value of 0.45 and has seen 74104.0 shares traded in the last trading session. The company, currently valued at $113.63M, closed the last trade at $6.80 per share which meant it lost -$0.04 on the day or -0.58% during that session. The COYA stock price is -57.21% off its 52-week high price of $10.69 and 30.15% above the 52-week low of $4.75. If we look at the company’s 10-day average daily trading volume, we find that it stood at 96600.0 shares traded. The 3-month trading volume is 67.23K shares.
The consensus among analysts is that Coya Therapeutics Inc (COYA) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.14.
Coya Therapeutics Inc (NASDAQ:COYA) trade information
Sporting -0.58% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the COYA stock price touched $6.80 or saw a rise of 6.21%. Year-to-date, Coya Therapeutics Inc shares have moved 18.67%, while the 5-day performance has seen it change -0.44%. Over the past 30 days, the shares of Coya Therapeutics Inc (NASDAQ:COYA) have changed 21.86%. Short interest in the company has seen 0.25 million shares shorted with days to cover at 5.04.
Wall Street analysts have a consensus price target for the stock at $18, which means that the shares’ value could jump 62.22% from current levels. The projected low price target is $18.0 while the price target rests at a high of $18.0. In that case, then, we find that the current price level is -164.71% off the targeted high while a plunge would see the stock gain -164.71% from current levels.
Coya Therapeutics Inc (COYA) estimates and forecasts
The company’s shares have gained 41.23% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -38.82%.
5 analysts offering their estimates for the company have set an average revenue estimate of 80k for the current quarter. 3 have an estimated revenue figure of 133.33k for the next ending quarter.
Earnings growth for 2025 is a modest -38.61% while over the next 5 years, the company’s earnings are expected to decrease by -18.06%.
COYA Dividends
Coya Therapeutics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Coya Therapeutics Inc (NASDAQ:COYA)’s Major holders
Insiders own 7.03% of the company shares, while shares held by institutions stand at 26.72% with a share float percentage of 28.74%. Investors are also buoyed by the number of investors in a company, with Coya Therapeutics Inc having a total of 33.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 3.33% shares in the company for having 556.9 shares of worth $3.79 million while later fund manager owns 256.43 shares of worth $1.74 million as of Sep 30, 2024, which makes it owner of about 1.53% of company’s outstanding stock.
